vs
Apellis Pharmaceuticals, Inc.（APLS）与HAVERTY FURNITURE COMPANIES INC（HVT）财务数据对比。点击上方公司名可切换其他公司
HAVERTY FURNITURE COMPANIES INC的季度营收约是Apellis Pharmaceuticals, Inc.的1.0倍（$201.9M vs $199.9M），HAVERTY FURNITURE COMPANIES INC净利率更高（4.2% vs -29.5%，领先33.7%），HAVERTY FURNITURE COMPANIES INC同比增速更快（9.5% vs -5.9%），HAVERTY FURNITURE COMPANIES INC自由现金流更多（$3.0M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 4.8%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
该企业原名为国际鞋业公司，1911年由两家鞋企合并成立于美国密苏里州克莱顿，后开展多元化业务并逐步退出制鞋领域，最终更名为家具品牌国际，是美国家居行业知名企业，曾拥有布罗伊希尔等多个知名家具品牌。
APLS vs HVT — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $201.9M |
| 净利润 | $-59.0M | $8.5M |
| 毛利率 | — | 60.4% |
| 营业利润率 | -25.6% | 5.3% |
| 净利率 | -29.5% | 4.2% |
| 营收同比 | -5.9% | 9.5% |
| 净利润同比 | -62.2% | 4.1% |
| 每股收益（稀释后） | $-0.40 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $199.9M | $201.9M | ||
| Q3 25 | $458.6M | $194.5M | ||
| Q2 25 | $178.5M | $181.0M | ||
| Q1 25 | $166.8M | $181.6M | ||
| Q4 24 | $212.5M | $184.4M | ||
| Q3 24 | $196.8M | $175.9M | ||
| Q2 24 | $199.7M | $178.6M | ||
| Q1 24 | $172.3M | $184.0M |
| Q4 25 | $-59.0M | $8.5M | ||
| Q3 25 | $215.7M | $4.7M | ||
| Q2 25 | $-42.2M | $2.7M | ||
| Q1 25 | $-92.2M | $3.8M | ||
| Q4 24 | $-36.4M | $8.2M | ||
| Q3 24 | $-57.4M | $4.9M | ||
| Q2 24 | $-37.7M | $4.4M | ||
| Q1 24 | $-66.4M | $2.4M |
| Q4 25 | — | 60.4% | ||
| Q3 25 | — | 60.3% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 61.2% | ||
| Q4 24 | — | 61.9% | ||
| Q3 24 | — | 60.2% | ||
| Q2 24 | — | 60.4% | ||
| Q1 24 | — | 60.3% |
| Q4 25 | -25.6% | 5.3% | ||
| Q3 25 | 48.7% | 3.3% | ||
| Q2 25 | -18.6% | 2.4% | ||
| Q1 25 | -50.0% | 2.9% | ||
| Q4 24 | -12.3% | 5.2% | ||
| Q3 24 | -24.0% | 3.9% | ||
| Q2 24 | -14.7% | 3.6% | ||
| Q1 24 | -36.0% | 1.7% |
| Q4 25 | -29.5% | 4.2% | ||
| Q3 25 | 47.0% | 2.4% | ||
| Q2 25 | -23.6% | 1.5% | ||
| Q1 25 | -55.3% | 2.1% | ||
| Q4 24 | -17.1% | 4.4% | ||
| Q3 24 | -29.2% | 2.8% | ||
| Q2 24 | -18.9% | 2.5% | ||
| Q1 24 | -38.5% | 1.3% |
| Q4 25 | $-0.40 | — | ||
| Q3 25 | $1.67 | — | ||
| Q2 25 | $-0.33 | — | ||
| Q1 25 | $-0.74 | — | ||
| Q4 24 | $-0.30 | — | ||
| Q3 24 | $-0.46 | — | ||
| Q2 24 | $-0.30 | — | ||
| Q1 24 | $-0.54 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $125.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $307.9M |
| 总资产 | $1.1B | $649.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $466.2M | $125.3M | ||
| Q3 25 | $479.2M | $130.5M | ||
| Q2 25 | $370.0M | $107.4M | ||
| Q1 25 | $358.4M | $111.9M | ||
| Q4 24 | $411.3M | $120.0M | ||
| Q3 24 | $396.9M | $121.2M | ||
| Q2 24 | $360.1M | $109.9M | ||
| Q1 24 | $325.9M | $111.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
| Q4 25 | $370.1M | $307.9M | ||
| Q3 25 | $401.2M | $306.0M | ||
| Q2 25 | $156.3M | $304.9M | ||
| Q1 25 | $164.2M | $305.4M | ||
| Q4 24 | $228.5M | $307.6M | ||
| Q3 24 | $237.1M | $307.8M | ||
| Q2 24 | $264.3M | $307.1M | ||
| Q1 24 | $266.7M | $306.7M |
| Q4 25 | $1.1B | $649.1M | ||
| Q3 25 | $1.1B | $651.7M | ||
| Q2 25 | $821.4M | $642.7M | ||
| Q1 25 | $807.3M | $642.7M | ||
| Q4 24 | $885.1M | $648.7M | ||
| Q3 24 | $901.9M | $659.3M | ||
| Q2 24 | $904.5M | $642.1M | ||
| Q1 24 | $831.9M | $640.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $7.4M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $3.0M |
| 自由现金流率自由现金流/营收 | -7.1% | 1.5% |
| 资本支出强度资本支出/营收 | 0.1% | 2.2% |
| 现金转化率经营现金流/净利润 | — | 0.86× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $33.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-14.2M | $7.4M | ||
| Q3 25 | $108.5M | $31.9M | ||
| Q2 25 | $4.4M | $7.2M | ||
| Q1 25 | $-53.4M | $6.2M | ||
| Q4 24 | $19.4M | $16.9M | ||
| Q3 24 | $34.1M | $24.4M | ||
| Q2 24 | $-8.3M | $14.4M | ||
| Q1 24 | $-133.0M | $3.1M |
| Q4 25 | $-14.3M | $3.0M | ||
| Q3 25 | $108.3M | $28.3M | ||
| Q2 25 | $4.4M | $1.6M | ||
| Q1 25 | $-53.4M | $27.0K | ||
| Q4 24 | $19.3M | $9.1M | ||
| Q3 24 | — | $16.1M | ||
| Q2 24 | $-8.4M | $4.9M | ||
| Q1 24 | $-133.3M | $-3.3M |
| Q4 25 | -7.1% | 1.5% | ||
| Q3 25 | 23.6% | 14.6% | ||
| Q2 25 | 2.5% | 0.9% | ||
| Q1 25 | -32.0% | 0.0% | ||
| Q4 24 | 9.1% | 4.9% | ||
| Q3 24 | — | 9.2% | ||
| Q2 24 | -4.2% | 2.7% | ||
| Q1 24 | -77.3% | -1.8% |
| Q4 25 | 0.1% | 2.2% | ||
| Q3 25 | 0.0% | 1.8% | ||
| Q2 25 | 0.0% | 3.1% | ||
| Q1 25 | 0.0% | 3.4% | ||
| Q4 24 | 0.0% | 4.2% | ||
| Q3 24 | 0.0% | 4.7% | ||
| Q2 24 | 0.0% | 5.3% | ||
| Q1 24 | 0.2% | 3.5% |
| Q4 25 | — | 0.86× | ||
| Q3 25 | 0.50× | 6.75× | ||
| Q2 25 | — | 2.69× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 2.06× | ||
| Q3 24 | — | 4.96× | ||
| Q2 24 | — | 3.25× | ||
| Q1 24 | — | 1.31× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
HVT
| Upholstery | $91.0M | 45% |
| Bedroom Furniture | $29.2M | 14% |
| Accessories And Other | $28.4M | 14% |
| Dining Room Furniture | $22.8M | 11% |
| Mattresses | $16.1M | 8% |
| Occasional | $14.4M | 7% |
